AbbVie Inc.
ABBV 179.44 (0.98%) 1.76
317.10(B)
Health Care
Biotechnology
Holdings:
Shares:
Cost basis:
AbbVie Inc. (ABBV) price target and intrinsic value estimate
ABBV's fair price estimate is $170.6
This valuation is based on a fair P/E of 15.9 and EPS estimates of $10.72
The median analyst price target for ABBV is $205.0.
Analyst price targets range from $165.0 to $240.0
Is ABBV overvalued or undervalued?
ABBV is currently trading at $179.44
ABBV is overvalued by 5% using the pevaluation method.
ABBV is undervalued by 12% compared to median analyst price targets.
Do you agree with this valuation?
Valuation
PEvaluation
Low $127.9
Median $170.6
High $213.2
Fair P/E
Margin of safety
Analyst valuation
Low $165.0
Median $205.0
High $240.0
Discounted cash-flow
10%
5%
5y
10%
Economic moat: Wide
Overview
Market data
Market cap:$317.10(B)
Enterprise value:$377.11(B)
Total Equity:$6.07(B)
Shares outstanding:1.77(B)
Div. yield:3.46%
P/S:5.71
P/E:62.52
P/FCF:20.30
P/B:52.62
EPS:$2.9
FCF per share:$8.8
Dividend per share:$6.2
Income (TTM)
Revenue$55.53(B)
Gross profit$39.06(B)
EBITDA$25.63(B)
Net income$5.12(B)
Gross margin70.3%
Net margin9.2%
Balance sheet
Total assets$143.42(B)
Total liabilities$137.35(B)
Cash & Short-term inv.$7.29(B)
Long-term debt$58.75(B)
Debt issued$19.97(B)
Debt repaid$-10.65(B)
Cash flow (TTM)
FCF$15.62(B)
CapEx$-888.00(M)
Dividends paid$-10.90(B)
Stock issued$235.00(M)
Stock repurchased$-1.35(B)
Stock-based comp.$872.00(M)
Future Growth
Revenue
CAGR: 6.3%FY+1$56.04(B)
FY+2$59.23(B)
FY+3$63.56(B)
FY+4$67.36(B)
FY+5$71.59(B)
Net Income
CAGR: 10.6%FY+1$19.44(B)
FY+2$21.63(B)
FY+3$24.22(B)
FY+4$26.57(B)
FY+5$29.05(B)
EPS
CAGR: 10.8%FY+1$10.94
FY+2$12.18
FY+3$13.65
FY+4$15.07
FY+5$16.50
FCF per share
CAGR: 13.5%FY+1$10.85
FY+2$12.56
FY+3$14.21
FY+4$16.60
FY+5$18.02
Similar Companies
Historical Financials
Showing limited histrical data. Access 10+ years of financials now! Upgrade
Income
RevenueNet IncomeCOGSGross ProfitTotal OpEx.R&DSG&AOperating IncomeInterest ExpenseInterest IncomePre-tax incomeIncome tax
Cash flow
FCFCFONet IncomeD&AStock-based Comp.CFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Shares outstanding
Shares (Basic)Shares (Diluted)
Per share data
EPS (Basic)EPS (Diluted)FCF/ShareDividend/ShareBook value/Share
Ratios
P/EP/FCFP/BP/SEV/EarningsEV/FCFDebt/EquityPayout ratio
Margins
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
ROICROAROCEROE
Market Cap.
Market Cap.